MAPS Statement on Bipartisan Congressional Letter to FDA

By Zane Bader

Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to Food and Drug Administration (FDA) Commissioner Martin A. Makary, urging the agency to advance evaluation of psychedelic-assisted therapies. The letter asks FDA to respond to a series of questions at the center of the evaluation of MDMA-assisted therapy for PTSD that MAPS originated and advanced fo

← Prev Vibe Read Full Article at Source →Next Vibe →

MAPS Statement on Bipartisan Congressional Letter to FDA

Read Article →

More from Alter

🌿 Alter

LeaflyInsider·2h ago

Runtz x Gelato #41 Crosses Are Commanding $80/Eighth in LA

Small-batch craft genetics with terpene profiles that rival Sonoma County wine.

Find Near You →

🌿 Alter

VaporNation·6h ago

Volcano Classic vs. Mighty+: The Definitive Vaporizer Comparison

After 200 hours of testing, we know which one actually delivers on flavor retention.

See Best Prices →

🌿 Alter

Marijuana Moment·3h ago

Rhode Island Marijuana Business License Lottery Blocked By Federal Judge Amid Challenge To Residency Rules

“Knowing the Act was facing legal challenges…CCC continued forward with its plan to implement the Act and its licensing scheme. The resulting fall-out will be, to be blunt, self-inflicted.” By Christopher Shea, Rho

Read Full Article →

🌿 Alter

Marijuana Moment·5h ago

Cleveland City Council Proposal Would Use Marijuana Tax Money To Support Neighborhood Projects

“Legalization created opportunity. This ordinance ensures that this opportunity is shared, shared fairly, shared transparently and shared with the residents who made it possible.” By Nick Castele, Signal Cleveland This

Read Full Article →